Literature DB >> 1800371

Beta-lactamase production in Branhamella catarrhalis isolated from lower respiratory tract secretions in Danish children: an increasing problem.

T Ejlertsen1, H C Schønheyder, E Thisted.   

Abstract

Findings in specimens from the lower respiratory tract of children were reviewed retrospectively in order to assess the rate of Branhamella catarrhalis and beta-lactamase production. B. catarrhalis was isolated in 139 of 756 samples (18.4%) in 1986 and 211 of 723 samples (29.2%) in 1989. Beta-lactamase production was found in 55.6% of B. catarrhalis strains in 1986 and 80.1% in 1989 (p less than 0.001). Prevalence of beta-lactamase in B. catarrhalis has now reached the same level in Europe as in the USA.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1800371     DOI： 10.1007/BF01645357

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  21 in total

1.  Branhamella catarrhalis in lower respiratory tract secretions in adults.

Authors:  H Schønheyder; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

2.  Emergence and persistence of beta-lactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics.

Authors:  I Eliasson; E Holst; S Mölstad; C Kamme
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

3.  Antimicrobial resistance in Branhamella catarrhalis.

Authors:  T V Riley
Journal:  J Antimicrob Chemother       Date:  1988-02       Impact factor: 5.790

4.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

5.  In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.

Authors:  B E Malmvall; J E Brorsson; J Johnsson
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

6.  Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

Authors:  A Percival; J E Corkill; J Rowlands; R B Sykes
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

7.  Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media.

Authors:  C Kamme
Journal:  Scand J Infect Dis       Date:  1970

8.  Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.

Authors:  J J Christensen; J Keiding; B Bruun
Journal:  APMIS       Date:  1990-11       Impact factor: 3.205

9.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04
View more
  2 in total

1.  Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.

Authors:  S C Sehgal; I al Shaimy
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

2.  Parenteral-oral switch in the management of paediatric pneumonia.

Authors:  R Dagan; G Syrogiannopoulos; S Ashkenazi; D Engelhard; M Einhorn; M Gatzola-Karavelli; I Shalit; J Amir
Journal:  Drugs       Date:  1994       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.